BHST
BioHarvest Sciences, Inc.
NASDAQ · Basic Materials · Agricultural Inputs · CA
$1.72
+2.38%Oct 13, 2026, 13:27 UTC
BioHarvest Sciences said Olive Cell, an olive-derived plant-cell ingredient, is ready for commercial licensing after completing large-scale bioreactor scale-up, manufacturing readiness and a self-affirmed U.S. GRAS process.
Source:Oct 8, 2026, 12:00 UTC
Tate & Lyle Plc and BIOHARVEST SCIENCES INC. announced that their next-generation sweetener development programme demonstrated BioHarvest's Botanical Synthesis platform can produce the targeted sweetening solution.
Source:Sep 29, 2026, 11:00 UTC
BioHarvest Sciences Inc.'s Board of Directors authorized a share repurchase program structured as a normal course issuer bid under Canadian practices.
Sep 15, 2026, 11:00 UTC
BioHarvest Sciences Inc. announced the launch of single-dose VINIA Daily Chews, a new delivery format for its VINIA product.
Source:Sep 3, 2026, 11:00 UTC
BioHarvest Sciences Inc. announced its intention to list its ordinary shares on the Tel Aviv Stock Exchange, becoming dual-listed on Nasdaq and TASE, with trading expected to begin on September 8, 2026.
Aug 13, 2026, 16:23 UTC
BioHarvest signed a $20M–$30M deal to grow one of the world's costliest perfume ingredients in bioreactors.
Source:Aug 11, 2026, 10:30 UTC
BioHarvest Sciences reported Q2 2026 revenue of $8.8 million, up 3.8% from Q2 2025.
Aug 11, 2026, 10:01 UTC
BioHarvest Sciences announced an exclusive manufacturing and supply agreement with an undisclosed UAE-based customer to secure production of a rare, endangered fragrance plant cell culture, extending the terms of their original agreement.
Jul 15, 2026, 11:30 UTC
BioHarvest Sciences Inc received a $1.4 million grant from the Israel Innovation Authority to fund AI-driven plant-cell synthesis research.